Optimizing CAR-NK Cell Transduction and Expansion: Leveraging Cytokine Modulation for Enhanced Performance

Area of Science:

• Immunology
• Cellular Therapy
• Oncology

Background:

• Cellular immunotherapies like CAR T-cells show promise for leukemia and lymphoma but carry risks of severe adverse events and graft-versus-host reactions.
• Natural Killer (NK) cell immunotherapy offers a safer allogeneic approach, but efficient genetic modification of NK cells remains a challenge.
• Current limitations hinder the widespread application of T-cell-based therapies, necessitating exploration of alternative immune cell strategies.

Purpose of the Study:

• To present a detailed protocol for significantly enhancing the transduction efficiency of primary human NK cells.
• To establish a reliable method for preparing high-titer lentiviral particles for optimal NK cell modification.
• To provide a comprehensive guide for generating chimeric antigen receptor (CAR)-NK cells for cancer immunotherapy research.

Main Methods:

• Isolation of NK cells from human peripheral blood mononuclear cells (PBMCs).
• Short-term culture of NK cells in cytokine-supplemented medium to enhance transduction.
• Preparation and titration of high-quality lentiviral particles (VSV-G pseudotyped).
• Transduction of NK cells with lentiviral vectors and subsequent expansion.

Main Results:

• The described method significantly improves the efficiency of lentiviral transduction in primary NK cells.
• The protocol facilitates the generation of functional CAR-NK cells suitable for further assays.
• Optimized lentivirus preparation and NK cell culture conditions are detailed.

Conclusions:

• This protocol provides a robust method for efficient genetic engineering of NK cells, overcoming previous limitations.
• Enhanced NK cell transduction paves the way for developing safer and more effective allogeneic immunotherapies for cancer.
• The detailed methodology supports the advancement of NK cell-based cancer treatments.